Infant Bacterial Therapeutics AB (publ) (STO:IBT.B)
75.00
+3.80 (5.34%)
Oct 13, 2026, 4:07 PM CET
Infant Bacterial Therapeutics AB Employees
Infant Bacterial Therapeutics AB had 6 employees as of December 31, 2025. The number of employees decreased by 2 or -25.00% compared to the previous year. That makes Infant Bacterial Therapeutics AB the 41,457th largest employer in the world and 693rd in Sweden.
Employees
6
Change (1Y)
-2
Growth (1Y)
-25.00%
Revenue / Employee
n/a
Profits / Employee
-13.65M SEK
Market Cap
1.01B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 6 | -2 | -25.00% |
| Dec 31, 2024 | 8 | 0 | - |
| Sep 30, 2024 | 10 | 2 | 25.00% |
| Jun 30, 2024 | 9 | 1 | 12.50% |
| Mar 31, 2024 | 8 | 0 | - |
| Dec 31, 2023 | 8 | 1 | 14.29% |
| Sep 30, 2023 | 8 | -2 | -20.00% |
| Jun 30, 2023 | 8 | 0 | - |
| Mar 31, 2023 | 8 | 0 | - |
| Dec 31, 2022 | 7 | -1 | -12.50% |
| Sep 30, 2022 | 10 | 2 | 25.00% |
| Jun 30, 2022 | 8 | 0 | - |
| Mar 31, 2022 | 8 | -1 | -11.11% |
| Dec 31, 2021 | 8 | -2 | -20.00% |
| Sep 30, 2021 | 8 | -2 | -20.00% |
| Jun 30, 2021 | 8 | -2 | -20.00% |
| Mar 31, 2021 | 9 | -1 | -10.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| BioInvent International AB | 108 |
| Oncopeptides AB | 69 |
| Saniona AB | 44 |
| Genovis AB (publ.) | 42 |
| Sprint Bioscience AB | 32 |
| Xspray Pharma AB | 24 |
| AlzeCure Pharma AB | 10 |
| SynAct Pharma AB | 8 |
Infant Bacterial Therapeutics AB News
- 6 weeks ago - Infant Bacterial Therapeutics AB Quarterly report: Q2 2026 - Filings
- 5 months ago - Infant Bacterial Therapeutics AB Quarterly report: Q1 2026 - Filings
- 8 months ago - Infant Bacterial Therapeutics AB Annual report: Q4 2025 - Filings
- 8 months ago - Infant Bacterial Therapeutics AB Quarterly report: Q4 2025 - Filings
- 11 months ago - Infant Bacterial Therapeutics AB Quarterly report: Q3 2025 - Filings